SCHEMBL31437066

SCHEMBL31437066

CC(C)(C)OC(=O)NC1CCN(S(=O)(=O)c2cccc(N3CCNCC3)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.49
PKM P14618 2/20 0.46
HTR6 P50406 5/20 0.45
NAMPT P43490 1/20 0.44
KMT2A Q03164 4/20 0.44
ALDH1A1 P00352 2/20 0.44
EPHX2 P34913 1/20 0.43
BRD4 O60885 2/20 0.43
HTR1A P08908 2/20 0.43
DRD2 P14416 2/20 0.43
HTR2A P28223 2/20 0.43
HTR7 P34969 2/20 0.43
TSHR P16473 1/20 0.43
MEN1 O00255 1/20 0.43
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24571615 1.00 GPR119 (0.49) GPR119PKMHTR6NAMPTKMT2A
SCHEMBL30915026 0.90 GPR119 (0.51) GPR119PKMNAMPTKMT2AALDH1A1
SCHEMBL31619968 0.90 GPR119 (0.51) GPR119PKMNAMPTKMT2AALDH1A1
SCHEMBL31437058 0.89 GPR119 (0.49) GPR119PKMNAMPTKMT2AALDH1A1
SCHEMBL24571911 0.89 GPR119 (0.49) GPR119PKMNAMPTKMT2AALDH1A1
SCHEMBL24572254 0.87 GPR119 (0.48) GPR119PKMNAMPTKMT2AALDH1A1
SCHEMBL24571752 0.87 GPR119 (0.48) GPR119PKMNAMPTKMT2AALDH1A1
SCHEMBL29641004 0.87 GPR119 (0.48) GPR119PKMNAMPTKMT2AALDH1A1
SCHEMBL29640930 0.87 GPR119 (0.48) GPR119PKMNAMPTKMT2AALDH1A1
SCHEMBL24571885 0.87 GPR119 (0.50) GPR119PKMNAMPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120152967-A Bifunctional compounds containing 2, 5-substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-06-13 CN disclosed
CN-119630644-A Bifunctional compounds containing pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed
CN-119630651-A Bifunctional compounds containing substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed